19.02.2016
MediClin AG DE0006595101
DGAP-News: MediClin AG: Group sales increased by EUR 17.3 mill. up to EUR 555.3 mill.; preliminary Group operating result amounts to EUR 23.6 mill.
DGAP-News: MediClin AG / Key word(s): Preliminary Results
MediClin AG: Group sales increased by EUR 17.3 mill. up to EUR 555.3 mill.;
preliminary Group operating result amounts to EUR 23.6 mill.
19.02.2016 / 13:10
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Group sales increased by EUR 17.3 mill. up to EUR 555.3 mill.; preliminary
Group operating result amounts to EUR 23.6 mill.
Offenburg, February 19, 2016 -MEDICLIN Aktiengesellschaft (MediClin)
achieved Group sales of EUR 555.3 mill. in the FY 2015. The sales plus was
EUR 17.3 mill. or 3.2% against previous year. The preliminary Group
operating result (Group-EBIT) increased from EUR 15.6 mill. to EUR 23.6
mill. and the preliminary result attributable to shareholders of MediClin
AG from EUR 8.5 mill. to EUR 16.5 mill. Earnings per share account to EUR
0.35 (previous year: EUR 0.18).
The largest share of sales growth posted the post-acute segment with EUR
16.5 mill. Especially the clinics contributed to this development which
offer additional medical services of acute-neurology and
acute-psychosomatic in the scope of an integrated care concept. The segment
achieved sales of EUR 330.9 mill. (previous year: EUR 314.4 mill.) The
nursing care business area accounted for EUR 14.1 mill. contributing EUR
1.0 mill. to sales growth. Sales of the acute segment amounted to EUR 206.7
mill., thus being EUR 0.6 mill. below previous years value, because only
eight medical care centres added to sales growth instead of ten as in the
previous year. Without the sales decrease of the medical care centres sales
in the acute segment would be up by EUR 0.7 mill. The segment results of
the post-acute and acute segment increased by EUR 4.0 mill. respectively
EUR 0.5 mill. against previous year. In the post-acute segment higher staff
costs could be more than compensated by significantly higher sales and
lower material costs compared to the previous year. In the acute segment
lower material costs and staff costs led to an increase of result despite a
slight decrease in sales.
In the FY 2015 about EUR 27.0 mill. (previous year: EUR 21,0 mill.) were
invested in capital expenditure including EUR 2.7 mill. (previous year: EUR
4.4 mill.) subsidies. As of December 31, 2015 cash and cash equivalents
amounted to EUR 29.5 mill. (31.12.2014: EUR 26.3 mill.); the equity ratio
was 51.3% (31.12.2014: 48.2%).
The press conference and the analysts and investors conference will take
place in Frankfurt on March 23, 2015. From that date onwards the annual
report 2015 will be available under www.mediclin.de in German and English.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics, 7 nursing care facilities and 8 medical care centres in 11 federal
states MediClin has a total capacity of approximately 8,000 beds.
MediClins' facilities include acute care clinics, i.e., general hospitals,
special treatment facilities, specialised hospitals and clinics for
post-acute treatment and medical rehabilitation. MediClin has approximately
9,000 employees.
MediClin ─ a company of the Asklepios Group
---------------------------------------------------------------------------
19.02.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart
End of News DGAP News Service
---------------------------------------------------------------------------
438645 19.02.2016
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
MediClin AG ISIN: DE0006595101 können Sie bei EQS abrufen
Pflegeeinrichtungen , 659510 , MED , XETR:MED